Aldoxorubicin

Drug identity checked against registry records

Also recorded as INNO-206

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
Efficacy and Safety of Aldoxorubicin Compared to Topotecan in Subjects With Metastatic Small Cell Lung CancerNCT02200757IBRXPhase 2Completed2017-05-15Actual
Phase 3 Study to Treat Patients With Soft Tissue SarcomasNCT02049905IBRXPhase 3Completed2017-05Actual

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.